|
LuverisDrug - Luveris The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; SUBCUTANEOUS
Active Ingredient(s) -
Lutropin Alfa
Strength -
75 IU/VIAL
Applicant -
SERONO INC
New Drug Application (NDA) Number -
021322
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Oct 8, 2004
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Serono Inc
Luveris
Loxitane Eq 10mg Base Capsule; Oral
Loxitane Eq 25mg Base Capsule; Oral Loxitane Eq 50mg Base Capsule; Oral Loxitane Eq 5mg Base Capsule; Oral Loxitane Eq 10mg Base Tablet; Oral Loxitane Eq 25mg Base Tablet; Oral Loxitane Eq 50mg Base Tablet; Oral Luveris 75 Iu/vial Injectable; Subcutaneous Loxapine Succinate Eq 50mg Base Capsule; Oral Loxapine Succinate Eq 5mg Base Capsule; Oral NewDrugInformation |